TickerFactsScreenerDevelopers

Aptose Biosciences Inc. (APTOF) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2017: $13.0K2018: $329.0K2019: $102.0K2020: $79.0K2021: $212.0K2022: $24.0K2023: $29.0K2024: $5.0K2025: $0$0
2017Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$5.0K-82.8%
2023$29.0K+20.8%
2022$24.0K-88.7%
2021$212.0K+168.4%
2020$79.0K-22.5%
2019$102.0K-69.0%
2018$329.0K+2430.8%
2017$13.0K—